Motivation: Mutual exclusivity is a widely recognized property of many cancer drivers. Knowledge about these relationships can provide important insights into cancer drivers, cancer-driving pathways and cancer subtypes. It can also be used to predict new functional interactions between cancer driving genes and uncover novel cancer drivers. Currently, most of mutual exclusivity analyses are preformed focusing on a limited set of genes in part due to the computational cost required to rigorously compute P -values. Results: To reduce the computing cost and perform less restricted mutual exclusivity analysis, we developed an efficient method to estimate P -values while controlling the mutation rates of individual patients and genes similar to the permutation test. A comprehensive mutual exclusivity analysis allowed us to uncover mutually exclusive pairs, some of which may have relatively low mutation rates. These pairs often included likely cancer drivers that have been missed in previous analyses. More importantly, our results demonstrated that mutual exclusivity can also provide information that goes beyond the interactions between cancer drivers and can, for example, elucidate different mutagenic processes in different cancer groups. In particular, including frequently mutated, long genes such as TTN in our analysis allowed us to observe interesting patterns of APOBEC activity in breast cancer and identify a set of related driver genes that are highly predictive of patient survival. In addition, we utilized our mutual exclusivity analysis in support of a previously proposed model where APOBEC activity is the underlying process that causes TP53 mutations in a subset of breast cancer cases. Availability and Implementation: http://www.ncbi.nlm.nih.gov/CBBresearch/Przytycka/index.cgi#wesme. Contact: przytyck@ncbi.nlm.nih.gov. Supplementary information: Supplementary data are available at Bioinformatics online. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Motivation: Mutual exclusivity is a widely recognized property of many cancer drivers. Knowledge about these relationships can provide important insights into cancer drivers, cancer-driving pathways and cancer subtypes. It can also be used to predict new functional interactions between cancer driving genes and uncover novel cancer drivers. Currently, most of mutual exclusivity analyses are preformed focusing on a limited set of genes in part due to the computational cost required to rigorously compute P -values. Results: To reduce the computing cost and perform less restricted mutual exclusivity analysis, we developed an efficient method to estimate P -values while controlling the mutation rates of individual patients and genes similar to the permutation test. A comprehensive mutual exclusivity analysis allowed us to uncover mutually exclusive pairs, some of which may have relatively low mutation rates. These pairs often included likely cancer drivers that have been missed in previous analyses. More importantly, our results demonstrated that mutual exclusivity can also provide information that goes beyond the interactions between cancer drivers and can, for example, elucidate different mutagenic processes in different cancer groups. In particular, including frequently mutated, long genes such as TTN in our analysis allowed us to observe interesting patterns of APOBEC activity in breast cancer and identify a set of related driver genes that are highly predictive of patient survival. In addition, we utilized our mutual exclusivity analysis in support of a previously proposed model where APOBEC activity is the underlying process that causes TP53 mutations in a subset of breast cancer cases. Availability and Implementation: http://www.ncbi.nlm.nih.gov/CBBresearch/Przytycka/index.cgi#wesme. Contact: przytyck@ncbi.nlm.nih.gov. Supplementary information: Supplementary data are available at Bioinformatics online. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Authors: Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker Journal: Genome Res Date: 2003-11 Impact factor: 9.043
Authors: Z Z Su; N I Goldstein; H Jiang; M N Wang; G J Duigou; C S Young; P B Fisher Journal: Proc Natl Acad Sci U S A Date: 1999-12-21 Impact factor: 11.205
Authors: Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris Journal: Nature Date: 2013-02-06 Impact factor: 49.962
Authors: Lori D Dwyer-Nield; Jay McQuillan; Annie Hill-Baskin; Richard A Radcliffe; Ming You; Joseph H Nadeau; Alvin M Malkinson Journal: Int J Cancer Date: 2010-01-01 Impact factor: 7.396
Authors: Ghia M Euskirchen; Raymond K Auerbach; Eugene Davidov; Tara A Gianoulis; Guoneng Zhong; Joel Rozowsky; Nitin Bhardwaj; Mark B Gerstein; Michael Snyder Journal: PLoS Genet Date: 2011-03-03 Impact factor: 5.917
Authors: Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz Journal: Nature Date: 2014-01-05 Impact factor: 49.962
Authors: Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding Journal: Nature Date: 2013-10-17 Impact factor: 49.962
Authors: Joris van de Haar; Sander Canisius; Michael K Yu; Emile E Voest; Lodewyk F A Wessels; Trey Ideker Journal: Cell Date: 2019-05-30 Impact factor: 41.582
Authors: Sisheng Liu; Jinpeng Liu; Yanqi Xie; Tingting Zhai; Eugene W Hinderer; Arnold J Stromberg; Nathan L Vanderford; Jill M Kolesar; Hunter N B Moseley; Li Chen; Chunming Liu; Chi Wang Journal: Bioinformatics Date: 2021-06-09 Impact factor: 6.937
Authors: Amanda I Phipps; Elizabeth Alwers; Tabitha Harrison; Barbara Banbury; Hermann Brenner; Peter T Campbell; Jenny Chang-Claude; Daniel Buchanan; Andrew T Chan; Alton B Farris; Jane C Figueiredo; Steven Gallinger; Graham G Giles; Mark Jenkins; Roger L Milne; Polly A Newcomb; Martha L Slattery; Mingyang Song; Shuji Ogino; Syed H Zaidi; Michael Hoffmeister; Ulrike Peters Journal: Gastroenterology Date: 2020-02-20 Impact factor: 22.682